4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-346995
Chief Executive Officer sold 51,499 shares at an average $47.25 ($2,433,176)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-08-10 | Sale 10b5-1 | −14,171 | $45.97 | $651,492 | 523,436 | D |
| Ceesay Abraham Chief Executive Officer | 2026-08-10 | Sale 10b5-1 | −8,370 | $46.75 | $391,280 | 515,066 | D |
| Ceesay Abraham Chief Executive Officer | 2026-08-11 | Sale 10b5-1 | −3,664 | $46.90 | $171,837 | 511,402 | D |
| Ceesay Abraham Chief Executive Officer | 2026-08-11 | Sale 10b5-1 | −19,500 | $48.04 | $936,846 | 491,902 | D |
| Ceesay Abraham Chief Executive Officer | 2026-08-11 | Sale 10b5-1 | −5,794 | $48.62 | $281,721 | 486,108 | D |
| Open-market sales · 51,499 sh · avg $47.25 · $2,433,176 | |||||||
Loading xslF345X06/ownership.xml…